Although its effectiveness and safety are mostly limited to empirical data, the ECDC, European Union competent authorities for blood and blood components, and WHO agree that CP from patients that have recovered from an infectious disease is a valuable treatment and/or pre-and post-exposure prophylactic resource for numerous infectious diseases. Here, CP is linked to infectious disease.